Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

TXG10x Genomics, Inc.

Nasdaq · CIK 0001770787
Filer categoryLarge accelerated filer
Entity typeoperating
SIC3826 Laboratory Analytical Instruments
FY end1231
XBRL facts334

Identity from submissions API

Name10x Genomics, Inc.
CIK0001770787
TickersTXG
ExchangesNasdaq
Entity typeoperating
CategoryLarge accelerated filer
SIC3826 Laboratory Analytical Instruments
EIN455614458
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone(925) 401-7300
Website—
Investor website—
Owner org08 Industrial Applications and Services
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
6230 STONERIDGE MALL ROAD
PLEASANTON
CA
94588
CA
Mailing address
6230 STONERIDGE MALL ROAD
PLEASANTON
CA
94588
CA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

702 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-20 144 xsl144X01/primary_doc.xml 0001950047-26-011398 001-39035 261579772 33 4894
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000080255-26-000713 005-91164 261556477 34 7791
2026-11-13 4 FORM 4 0001610717-26-000453 7664
2026-11-06 3 FORM 3 0001610717-26-000449 10765
2026-11-06 3 FORM 3 0001610717-26-000448 11356
2026-11-06 10-Q 10-Q 0001628280-26-071199 001-39035 261528703 34 6936927 1 1
2026-11-05 8-K 8-K 2.02,9.01 0001628280-26-071025 001-39035 261527239 34 1060418 1 1
2026-11-02 8-K 8-K 5.02 0001628280-26-068867 001-39035 261512296 34 675078 1 1
2026-10-07 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-114392 005-91164 261447617 34 13523
2026-09-24 4 FORM 4 0001610717-26-000422 12938
2026-09-24 4 FORM 4 0001610717-26-000421 15607
2026-09-22 144 xsl144X01/primary_doc.xml 0001968582-26-001003 001-39035 261397872 33 5701
2026-09-11 4 FORM 4 0001610717-26-000414 9175
2026-09-09 144 xsl144X01/primary_doc.xml 0001950047-26-009250 001-39035 261368470 33 6137
2026-09-08 4 FORM 4 0001610717-26-000405 8819
2026-09-08 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000080255-26-000600 005-91164 261363685 34 7660
2026-09-03 4 FORM 4 0001610717-26-000396 7278
2026-09-03 144 xsl144X01/primary_doc.xml 0001957799-26-000170 001-39035 261357919 33 5034
2026-08-28 4 FORM 4 0001610717-26-000393 11795
2026-08-26 144 xsl144X01/primary_doc.xml 0001968582-26-000886 001-39035 261324339 33 6169
2026-08-26 4 FORM 4 0001610717-26-000392 7968
2026-08-26 4 FORM 4 0001610717-26-000391 5350
2026-08-26 4 FORM 4 0001610717-26-000390 5430
2026-08-26 4 FORM 4 0001610717-26-000389 7222
2026-08-24 144 xsl144X01/primary_doc.xml 0001971187-26-000004 001-39035 261311983 33 4386
2026-08-24 144 xsl144X01/primary_doc.xml 0001786720-26-000003 001-39035 261311934 33 7438
2026-08-24 144 xsl144X01/primary_doc.xml 0001786391-26-000003 001-39035 261311891 33 4470
2026-08-24 144 xsl144X01/primary_doc.xml 0001968582-26-000871 001-39035 261311720 33 5574
2026-08-24 4 FORM 4 0001610717-26-000386 7279
2026-08-17 4 FORM 4 0001610717-26-000359 6222
2026-08-14 144 xsl144X01/primary_doc.xml 0001950047-26-008153 001-39035 261282773 33 6194
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-096964 005-91164 261280299 34 12769
2026-08-13 144 xsl144X01/primary_doc.xml 0001950047-26-008060 001-39035 261273662 33 4894
2026-08-13 4 FORM 4 0001610717-26-000358 6485
2026-08-11 144 xsl144X01/primary_doc.xml 0001957799-26-000152 001-39035 261261666 33 4419
2026-08-07 10-Q 10-Q 0001628280-26-054491 001-39035 261250579 34 6843972 1 1
2026-08-06 8-K 8-K 2.02,9.01 0001628280-26-054273 001-39035 261248785 34 1065501 1 1
2026-06-24 4 xslF345X06/form4.xml 0001610717-26-000293 13571
2026-06-18 4 xslF345X06/form4.xml 0001610717-26-000242 7058
2026-06-16 144 xsl144X01/primary_doc.xml 0001968582-26-000625 001-39035 261096329 33 12094
2026-06-08 4 xslF345X06/form4.xml 0001610717-26-000196 4871
2026-06-08 4 xslF345X06/form4.xml 0001610717-26-000195 13542
2026-06-08 4 xslF345X06/form4.xml 0001610717-26-000194 13552
2026-06-08 4 xslF345X06/form4.xml 0001610717-26-000193 13527
2026-06-08 4 xslF345X06/form4.xml 0001610717-26-000192 13603
2026-06-08 4 xslF345X06/form4.xml 0001610717-26-000191 14423
2026-06-08 8-K 8-K 5.07 0001628280-26-041651 001-39035 261073346 34 680935 1 1
2026-05-27 4 xslF345X06/form4.xml 0001610717-26-000164 9434
2026-05-27 4 xslF345X06/form4.xml 0001610717-26-000163 4821
2026-05-27 4 xslF345X06/form4.xml 0001610717-26-000162 4698
2026-05-26 144 xsl144X01/primary_doc.xml 0001968582-26-000489 001-39035 261020838 33 10759
2026-05-22 144 xsl144X01/primary_doc.xml 0001786720-26-000002 001-39035 261015635 33 354492
2026-05-22 144 xsl144X01/primary_doc.xml 0001786391-26-000002 001-39035 261015412 33 229952
2026-05-22 144 xsl144X01/primary_doc.xml 0001971187-26-000002 001-39035 261015238 33 116479
2026-05-08 10-Q 10-Q 0001628280-26-032388 001-39035 26955096 34 5774105 1 1
2026-05-07 8-K 8-K 2.02,9.01 0001628280-26-032073 001-39035 26953013 34 1018290 1 1
2026-04-29 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002100119-26-000076 005-91164 26916441 34 7450
2026-04-28 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002100121-26-000070 005-91164 26907321 34 7394
2026-04-24 DEFA14A DEFA14A 0001628280-26-027204 001-39035 26893745 34 429812
2026-04-24 DEF 14A DEF 14A 0001628280-26-027201 001-39035 26893688 34 35299975 1 1
2026-04-16 4 xslF345X06/form4.xml 0001610717-26-000145 7865
2026-03-25 4 xslF345X06/form4.xml 0001610717-26-000134 15270
2026-03-25 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000102909-26-000354 005-91164 26791706 34 7215
2026-03-24 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000102909-26-000351 005-91164 26786396 34 6333
2026-03-06 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000315066-26-000666 005-91164 26728999 34 14415
2026-03-04 4 xslF345X05/form4.xml 0001610717-26-000086 11002
2026-03-02 4 xslF345X05/form4.xml 0001610717-26-000077 7438
2026-03-02 4 xslF345X05/form4.xml 0001610717-26-000076 4899
2026-03-02 4 xslF345X05/form4.xml 0001610717-26-000075 4777
2026-03-02 144 xsl144X01/primary_doc.xml 0001968582-26-000191 001-39035 26708005 33 7147
2026-02-27 4 xslF345X05/form4.xml 0001610717-26-000074 13673
2026-02-25 4 xslF345X05/form4.xml 0001610717-26-000070 16390
2026-02-25 4 xslF345X05/form4.xml 0001610717-26-000069 13729
2026-02-25 4 xslF345X05/form4.xml 0001610717-26-000068 13836
2026-02-25 144 xsl144X01/primary_doc.xml 0001950047-26-001794 001-39035 26679610 33 5481
2026-02-23 144 xsl144X01/primary_doc.xml 0001786391-26-000001 001-39035 26666637 33 5042
2026-02-23 144 xsl144X01/primary_doc.xml 0001786720-26-000001 001-39035 26666460 33 5020
2026-02-23 144 xsl144X01/primary_doc.xml 0001971187-26-000001 001-39035 26666165 33 4949
2026-02-13 S-8 S-8 0001628280-26-008088 333-293461 26632625 33 337678 1 1
2026-02-13 10-K 10-K 0001628280-26-007822 001-39035 26627844 34 16359904 1 1
2026-02-12 8-K 8-K 2.02,9.01 0001628280-26-007673 001-39035 26626266 34 1065301 1 1
2026-01-12 8-K 8-K 2.02 0001628280-26-001808 001-39035 26526633 34 899736 1 1
2026-01-08 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000315066-26-000056 005-91164 26517758 34 14250
2026-01-07 4 xslF345X05/form4.xml 0001610717-26-000003 11198
2025-11-25 4 xslF345X05/form4.xml 0001610717-25-000400 4569
2025-11-25 4 xslF345X05/form4.xml 0001610717-25-000399 4684
2025-11-25 4 xslF345X05/form4.xml 0001610717-25-000398 7230
2025-11-24 144 xsl144X01/primary_doc.xml 0001786391-25-000004 001-39035 251514343 33 4440
2025-11-24 144 xsl144X01/primary_doc.xml 0001786720-25-000004 001-39035 251513917 33 4423
2025-11-24 144 xsl144X01/primary_doc.xml 0001971187-25-000004 001-39035 251513446 33 4356
2025-11-14 8-K 8-K 5.02 0001628280-25-052154 001-39035 251480301 34 667841 1 1
2025-11-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001140361-25-041820 005-91164 251475726 34 11330
2025-11-07 10-Q 10-Q 0001628280-25-050332 001-39035 251459766 34 6721612 1 1
2025-11-06 8-K 8-K 2.02,9.01 0001770787-25-000058 001-39035 251458268 34 1061868 1 1
2025-11-05 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000315066-25-002657 005-91164 251452506 34 14336
2025-11-04 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-106343 005-91164 251450174 34 13463
2025-10-30 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000102909-25-000030 005-91164 251433983 34 6262
2025-10-27 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001214659-25-015319 005-91164 251417383 34 12396
2025-09-16 4 xslF345X05/form4.xml 0001610717-25-000341 13119
2025-08-26 4 xslF345X05/form4.xml 0001610717-25-000321 8094
2025-08-26 4 xslF345X05/form4.xml 0001610717-25-000320 4558
2025-08-26 4 xslF345X05/form4.xml 0001610717-25-000319 4683
2025-08-22 144 xsl144X01/primary_doc.xml 0001610717-25-000309 001-39035 251246605 33 5055
2025-08-22 144 xsl144X01/primary_doc.xml 0001610717-25-000308 001-39035 251246556 33 5078
2025-08-22 144 xsl144X01/primary_doc.xml 0001610717-25-000307 001-39035 251246509 33 4975
2025-08-13 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001140361-25-030712 005-91164 251209194 34 10775
2025-08-12 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-076858 005-91164 251207022 34 15390
2025-08-08 10-Q 10-Q 0001770787-25-000051 001-39035 251195561 34 6423467 1 1
2025-08-07 8-K 8-K 2.02,9.01 0001770787-25-000048 001-39035 251194066 34 1065672 1 1
2025-08-07 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000315066-25-002176 005-91164 251192200 34 14061
2025-08-06 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000315066-25-001945 005-91164 251188227 34 14334
2025-07-31 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001214659-25-011169 005-91164 251169152 34 13242
2025-07-16 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002052113-25-002516 005-91164 251128480 34 11106
2025-06-11 4 xslF345X05/form4.xml 0001610717-25-000199 8080
2025-06-05 4 xslF345X05/form4.xml 0001610717-25-000172 4743
2025-06-05 4 xslF345X05/form4.xml 0001610717-25-000171 4701
2025-06-05 4 xslF345X05/form4.xml 0001610717-25-000170 4741
2025-06-05 4 xslF345X05/form4.xml 0001610717-25-000169 4707
2025-06-05 4 xslF345X05/form4.xml 0001610717-25-000168 4792
2025-06-05 4 xslF345X05/form4.xml 0001610717-25-000167 5585
2025-06-05 8-K 8-K 5.07 0001770787-25-000040 001-39035 251027185 34 680258 1 1
2025-06-02 4 xslF345X05/form4.xml 0001610717-25-000147 7897
2025-05-27 4 xslF345X05/form4.xml 0001610717-25-000144 8092
2025-05-27 4 xslF345X05/form4.xml 0001610717-25-000143 4682
2025-05-27 4 xslF345X05/form4.xml 0001610717-25-000142 4556
2025-05-22 144 xsl144X01/primary_doc.xml 0001610717-25-000127 001-39035 25977868 33 5088
2025-05-22 144 xsl144X01/primary_doc.xml 0001610717-25-000126 001-39035 25977732 33 4383
2025-05-22 144 xsl144X01/primary_doc.xml 0001610717-25-000125 001-39035 25977481 33 5818
2025-05-14 8-K 8-K 8.01 0001770787-25-000035 001-39035 25945268 34 679753 1 1
2025-05-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-048311 005-91164 25943511 34 13597
2025-05-12 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001140361-25-018346 005-91164 25934081 34 10912
2025-05-09 10-Q 10-Q 0001770787-25-000032 001-39035 25927587 34 6033616 1 1
2025-05-08 8-K 8-K 2.02,2.05,9.01 0001770787-25-000031 001-39035 25925907 34 1030215 1 1
2025-05-07 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000315066-25-001107 005-91164 25919901 34 14386
2025-05-07 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000315066-25-001093 005-91164 25919851 34 14518
2025-04-25 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001214659-25-006369 005-91164 25869797 34 11996
2025-04-15 DEFA14A DEFA14A 0001770787-25-000020 001-39035 25836983 34 250525
2025-04-14 DEF 14A DEF 14A 0001770787-25-000018 001-39035 25836322 34 36504858 1 1
2025-04-04 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-032177 005-91164 25813859 34 15084
2025-03-19 4 xslF345X05/form4.xml 0001610717-25-000075 8318
2025-03-19 4 xslF345X05/form4.xml 0001610717-25-000074 4908
2025-03-19 4 xslF345X05/form4.xml 0001610717-25-000073 6589
2025-03-04 4 xslF345X05/form4.xml 0001610717-25-000049 12287
2025-02-28 144 xsl144X01/primary_doc.xml 0001968582-25-000139 001-39035 25691913 33 4497
2025-02-26 4 xslF345X05/form4.xml 0001610717-25-000037 4690
2025-02-26 4 xslF345X05/form4.xml 0001610717-25-000036 8099
2025-02-25 4 xslF345X05/form4.xml 0001610717-25-000034 4886
2025-02-24 144 xsl144X01/primary_doc.xml 0001610717-25-000033 001-39035 25658870 33 5051
2025-02-24 144 xsl144X01/primary_doc.xml 0001610717-25-000032 001-39035 25658797 33 4464
2025-02-13 S-8 S-8 0001770787-25-000015 333-284894 25617604 33 279866
2025-02-13 10-K 10-K 0001770787-25-000013 001-39035 25616454 34 16514949 1 1
2025-02-12 8-K 8-K 2.02,9.01 0001770787-25-000011 001-39035 25614885 34 1081346 1 1
2025-01-13 8-K 8-K 2.02,9.01 0001770787-25-000003 001-39035 25525022 34 906372 1 1
2024-12-23 4 xslF345X05/form4.xml 0001610717-24-000554 10184
2024-11-25 4 xslF345X05/form4.xml 0001610717-24-000530 9468
2024-11-25 4 xslF345X05/form4.xml 0001610717-24-000529 4691
2024-11-22 144 xsl144X01/primary_doc.xml 0001610717-24-000528 001-39035 241490668 33 5054
2024-11-22 144 xsl144X01/primary_doc.xml 0001610717-24-000527 001-39035 241490416 33 5031
2024-11-18 4 xslF345X05/form4.xml 0001610717-24-000524 7903
2024-11-08 SC 13G SC 13G 0001140361-24-045803 005-91164 241440014 34 65375
2024-11-05 SC 13G txg1028240sc13g.htm 0001214659-24-018423 005-91164 241425442 34 63043
2024-10-29 10-Q 10-Q 0001770787-24-000073 001-39035 241405794 34 6786508 1 1
2024-10-29 8-K 8-K 2.02,5.02,9.01 0001770787-24-000071 001-39035 241405661 34 1058771 1 1
2024-10-09 8-K 8-K 2.02,9.01 0001770787-24-000064 001-39035 241362861 34 906989 1 1
2024-10-04 SC 13G/A UnitedStates_13G__10XGenomic.txt 0000932471-24-000175 005-91164 241354434 34 6676
2024-09-04 4 xslF345X05/form4.xml 0001610717-24-000461 4817
2024-08-26 4 xslF345X05/form4.xml 0001610717-24-000455 8100
2024-08-26 4 xslF345X05/form4.xml 0001610717-24-000454 4691
2024-08-26 4 xslF345X05/form4.xml 0001610717-24-000453 4646
2024-08-22 144 xsl144X01/primary_doc.xml 0001610717-24-000442 001-39035 241233294 33 5056
2024-08-22 144 xsl144X01/primary_doc.xml 0001610717-24-000441 001-39035 241233292 33 5007
2024-08-22 144 xsl144X01/primary_doc.xml 0001610717-24-000440 001-39035 241233280 33 5079
2024-08-20 3 xslF345X02/form3.xml 0001610717-24-000431 12433
2024-08-12 SC 13G SC 13G 0001104659-24-088193 005-91164 241195495 34 46491
2024-08-08 10-Q 10-Q 0001770787-24-000060 001-39035 241188448 34 5968827 1 1
2024-08-08 8-K 8-K 2.02,5.02,8.01,9.01 0001770787-24-000058 001-39035 241188301 34 1296243 1 1
2024-08-02 4 xslF345X05/form4.xml 0001610717-24-000410 4864
2024-07-19 3 xslF345X02/form3.xml 0001610717-24-000404 12532
2024-07-11 8-K 8-K 5.02 0001770787-24-000048 001-39035 241112136 34 682022 1 1
2024-06-26 3 xslF345X02/form3.xml 0001610717-24-000365 13223
2024-06-20 8-K 8-K 5.02 0001770787-24-000044 001-39035 241056337 34 680626 1 1
2024-06-13 4 xslF345X05/form4.xml 0001610717-24-000330 4747
2024-06-13 4 xslF345X05/form4.xml 0001610717-24-000329 5591
2024-06-13 4 xslF345X05/form4.xml 0001610717-24-000328 4713
2024-06-13 4 xslF345X05/form4.xml 0001610717-24-000327 4707
2024-06-13 4 xslF345X05/form4.xml 0001610717-24-000326 4729
2024-06-13 8-K 8-K 5.07 0001770787-24-000040 001-39035 241041280 34 693347 1 1
2024-06-07 SC 13G/A 10xGenomics31052024.txt 0001088875-24-000075 005-91164 241027725 34 10886
2024-06-06 DEFA14A DEFA14A 0001770787-24-000038 001-39035 241025187 34 28142
2024-05-31 4 xslF345X05/form4.xml 0001610717-24-000271 7902
2024-05-23 4 xslF345X05/form4.xml 0001610717-24-000259 4770
2024-05-23 4 xslF345X05/form4.xml 0001610717-24-000258 8099
2024-05-23 4 xslF345X05/form4.xml 0001610717-24-000257 4690
2024-05-22 144 xsl144X01/primary_doc.xml 0001230439-24-000020 001-39035 24973689 33 569259
2024-05-22 144 xsl144X01/primary_doc.xml 0001230439-24-000019 001-39035 24973606 33 560914
2024-05-22 144 xsl144X01/primary_doc.xml 0001230439-24-000018 001-39035 24973509 33 564006
2024-04-30 10-Q 10-Q 0001770787-24-000036 001-39035 24897277 34 5463054 1 1
2024-04-30 8-K 8-K 2.02,9.01 0001770787-24-000035 001-39035 24897132 34 1017694 1 1
2024-04-26 DEFA14A DEFA14A 0001770787-24-000030 001-39035 24883814 34 2455678
2024-04-26 DEF 14A DEF 14A 0001770787-24-000029 001-39035 24883604 34 34423509 1 1
2024-04-12 PRE 14A PRE 14A 0001770787-24-000024 001-39035 24841793 34 34340096 1 1
2024-03-25 4 xslF345X05/form4.xml 0001610717-24-000186 8316
2024-03-25 4 xslF345X05/form4.xml 0001610717-24-000185 4907
2024-03-25 4 xslF345X05/form4.xml 0001610717-24-000184 4808
2024-03-18 4 xslF345X05/form4.xml 0001610717-24-000163 8095
2024-03-06 4 xslF345X05/form4.xml 0001610717-24-000135 8390
2024-03-04 144 xsl144X01/primary_doc.xml 0001230439-24-000004 001-39035 24717306 33 9807
2024-02-26 4 xslF345X05/form4.xml 0001610717-24-000092 8099
2024-02-26 4 xslF345X05/form4.xml 0001610717-24-000091 4690
2024-02-26 4 xslF345X05/form4.xml 0001610717-24-000090 4590
2024-02-22 144 xsl144X01/primary_doc.xml 0001230439-24-000003 001-39035 24666765 33 9138
2024-02-22 144 xsl144X01/primary_doc.xml 0001230439-24-000002 001-39035 24666749 33 4317
2024-02-22 144 xsl144X01/primary_doc.xml 0001230439-24-000001 001-39035 24666726 33 4386
2024-02-20 4 xslF345X05/form4.xml 0001610717-24-000071 10488
2024-02-15 S-8 S-8 0001770787-24-000019 333-277120 24645009 33 289656
2024-02-15 10-K 10-K 0001770787-24-000017 001-39035 24644838 34 16301336 1 1
2024-02-15 8-K 8-K 2.02,9.01 0001770787-24-000015 001-39035 24643789 34 1066594 1 1
2024-02-13 4 xslF345X05/form4.xml 0001610717-24-000058 8598
2024-02-13 SC 13G/A SCHEDULE 13G/A 0001104659-24-020141 005-91164 24627173 34 13149
2024-02-09 SC 13G/A filing.txt 0000315066-24-000996 005-91164 24611354 34 10543
2024-01-31 SC 13G/A us88025u1097_013124.txt 0001086364-24-006012 005-91164 24582098 34 13774
2024-01-29 SC 13G/A 10xGenomics29122023.txt 0001088875-24-000042 005-91164 24571755 34 11315
2024-01-18 4 xslF345X05/form4.xml 0001610717-24-000030 10488
2024-01-16 144 xsl144X01/primary_doc.xml 0001968582-24-000041 001-39035 24536307 33 7659
2024-01-16 8-K 8-K 5.02 0001770787-24-000007 001-39035 24535216 34 676967 1 1
2024-01-08 8-K 8-K 2.02,9.01 0001770787-24-000004 001-39035 24518596 34 905604 1 1
2023-12-29 4 xslF345X05/form4.xml 0001610717-23-000427 6692
2023-12-29 4 xslF345X05/form4.xml 0001610717-23-000426 10380
2023-12-18 4 xslF345X05/form4.xml 0001610717-23-000402 10489
2023-12-14 144 xsl144X01/primary_doc.xml 0001968582-23-000776 001-39035 231487896 33 6384
2023-12-08 SC 13G/A MS AMENDMENT 0000895421-23-000505 005-91164 231475951 34 12790
2023-11-27 4 xslF345X05/form4.xml 0001610717-23-000367 4485
2023-11-27 4 xslF345X05/form4.xml 0001610717-23-000366 4586
2023-11-27 4 xslF345X05/form4.xml 0001610717-23-000365 4486
2023-11-27 4 xslF345X05/form4.xml 0001610717-23-000364 9846
2023-11-22 4 xslF345X05/form4.xml 0001610717-23-000361 4957
2023-11-22 144 xsl144X01/primary_doc.xml 0001230439-23-000023 001-39035 231433872 33 7877
2023-11-22 144 xsl144X01/primary_doc.xml 0001230439-23-000022 001-39035 231433833 33 4276
2023-11-22 144 xsl144X01/primary_doc.xml 0001230439-23-000021 001-39035 231433817 33 4345
2023-11-22 144 xsl144X01/primary_doc.xml 0001230439-23-000017 001-39035 231433481 33 4882
2023-11-20 144 xsl144X01/primary_doc.xml 0001972362-23-000999 001-39035 231423905 33 4813
2023-11-16 4 xslF345X05/form4.xml 0001610717-23-000358 8494
2023-11-03 10-Q 10-Q 0001770787-23-000053 001-39035 231374057 34 6153527 1 1
2023-11-02 8-K 8-K 2.02,9.01 0001770787-23-000051 001-39035 231372217 34 1063264 1 1
2023-10-18 4 xslF345X05/form4.xml 0001610717-23-000312 9900
2023-09-18 4 xslF345X05/form4.xml 0001610717-23-000280 11747
2023-09-14 144 xsl144X01/primary_doc.xml 0001968582-23-000510 001-39035 231255865 33 6909
2023-08-24 4 xslF345X05/form4.xml 0001610717-23-000238 7995
2023-08-24 4 xslF345X05/form4.xml 0001610717-23-000237 4486
2023-08-24 4 xslF345X05/form4.xml 0001610717-23-000236 4486
2023-08-24 4 xslF345X05/form4.xml 0001610717-23-000235 4586
2023-08-16 4 xslF345X05/form4.xml 0001610717-23-000228 9901
2023-08-04 10-Q 10-Q 0001770787-23-000047 001-39035 231141705 34 5996503 1 1
2023-08-03 4 xslF345X05/form4.xml 0001610717-23-000222 10536
2023-08-03 8-K 8-K 2.02,9.01 0001770787-23-000045 001-39035 231139857 34 1061326 1 1
2023-07-21 4 xslF345X05/form4.xml 0001610717-23-000215 12061
2023-07-21 4 xslF345X05/form4.xml 0001610717-23-000214 12028
2023-07-21 144 xsl144X01/primary_doc.xml 0001968582-23-000348 001-39035 231102195 33 4544
2023-07-20 8-K 8-K 5.02 0001770787-23-000038 001-39035 231099783 34 675630 1 1
2023-07-18 4 xslF345X05/form4.xml 0001610717-23-000205 10383
2023-07-10 SC 13G/A MS AMENDMENT 0000895421-23-000364 005-91164 231080200 34 17735
2023-07-10 SC 13G/A filing.txt 0000315066-23-002370 005-91164 231078543 34 10420
2023-06-16 4 xslF345X04/form4.xml 0001610717-23-000177 10275
2023-06-16 4 xslF345X04/form4.xml 0001610717-23-000176 6908
2023-06-16 4 xslF345X04/form4.xml 0001610717-23-000175 6945
2023-06-16 4 xslF345X04/form4.xml 0001610717-23-000174 6914
2023-06-16 4 xslF345X04/form4.xml 0001610717-23-000173 6931
2023-06-16 4 xslF345X04/form4.xml 0001610717-23-000172 7793
2023-06-16 4 xslF345X04/form4.xml 0001610717-23-000171 13636
2023-06-16 8-K 8-K 5.07 0001770787-23-000034 001-39035 231022006 34 713441 1 1
2023-06-14 144 xsl144X01/primary_doc.xml 0001968582-23-000239 001-39035 231015297 33 7080
2023-06-07 4 xslF345X04/form4.xml 0001610717-23-000099 4716
2023-05-25 4 xslF345X04/form4.xml 0001610717-23-000066 8833
2023-05-25 4 xslF345X04/form4.xml 0001610717-23-000065 4667
2023-05-25 4 xslF345X04/form4.xml 0001610717-23-000064 8913
2023-05-23 4 xslF345X04/form4.xml 0001610717-23-000062 10202
2023-05-19 4 xslF345X04/form4.xml 0001610717-23-000053 11295
2023-05-17 8-K 8-K 8.01,9.01 0001770787-23-000031 001-39035 23932996 34 944311 1 1
2023-05-17 4 xslF345X04/form4.xml 0001610717-23-000045 10383
2023-05-15 4 xslF345X04/form4.xml 0001610717-23-000035 8267
2023-05-11 144 xsl144X01/primary_doc.xml 0001972362-23-000122 001-39035 23912404 33 4163
2023-05-04 10-Q 10-Q 0001770787-23-000029 001-39035 23889829 34 5272377 1 1
2023-05-03 8-K 8-K 2.02,9.01 0001770787-23-000026 001-39035 23883625 34 1040160 1 1
2023-04-28 DEFA14A DEFA14A 0001770787-23-000022 001-39035 23867372 34 2445005
2023-04-28 DEF 14A DEF 14A 0001770787-23-000021 001-39035 23867243 34 5200337 1 1
2023-04-18 4 xslF345X04/form4.xml 0001610717-23-000013 12241
2023-03-23 4 xslF345X04/form4.xml 0001140361-23-013504 9452
2023-03-23 4 xslF345X04/form4.xml 0001140361-23-013505 9553
2023-03-23 4 xslF345X04/form4.xml 0001140361-23-013506 12964
2023-03-23 4 xslF345X04/form4.xml 0001140361-23-013503 9444
2023-03-16 4 FORM 4 0001567619-23-005183 11061
2023-03-09 4 FORM 4 0001567619-23-004744 8053
2023-02-24 4 FORM 4 0001567619-23-003782 4785
2023-02-24 4 FORM 4 0001567619-23-003780 4843
2023-02-24 4 FORM 4 0001567619-23-003779 8252
2023-02-16 S-8 S-8 0001770787-23-000014 333-269837 23639300 33 599786
2023-02-16 10-K 10-K 0001770787-23-000012 001-39035 23639114 34 24735001 1 1
2023-02-15 8-K 8-K 2.02,9.01 0001770787-23-000006 001-39035 23635369 34 1035247 1 1
2023-02-14 SC 13G/A SC 13G/A 0001104659-23-021530 005-91164 23628785 34 68769
2023-02-09 SC 13G/A SCHEDULE 13G/A 0001104659-23-015171 005-91164 23602141 34 13045
2023-02-09 SC 13G/A filing.txt 0000315066-23-001352 005-91164 23601209 34 10371
2023-02-08 SC 13G/A 10xGenomicsIncTXG.txt 0000895421-23-000013 005-91164 23597720 34 17546
2023-02-01 SC 13G/A us88025u1097_020123.txt 0001306550-23-006443 005-91164 23577518 34 13515
2023-01-18 SC 13G/A 10xGenomics30122022.txt 0001088875-23-000004 005-91164 23532882 34 11210
2022-12-16 4 FORM 4 0001567619-22-021727 6857
2022-12-14 4 FORM 4 0001567619-22-021571 11565
2022-11-23 4 FORM 4 0001567619-22-020871 7992
2022-11-23 4 FORM 4 0001567619-22-020870 7785
2022-11-23 4 FORM 4 0001567619-22-020869 7906
2022-11-03 10-Q 10-Q 0001770787-22-000057 001-39035 221355842 34 6772034 1 1
2022-11-02 8-K 8-K 2.02,9.01 0001770787-22-000053 001-39035 221354000 34 1031250 1 1
2022-09-16 4 FORM 4 0001567619-22-017566 7986
2022-09-16 4 FORM 4 0001567619-22-017565 9791
2022-09-16 4 FORM 4 0001567619-22-017564 9849
2022-09-16 4 FORM 4 0001567619-22-017561 7393
2022-09-16 4 FORM 4 0001567619-22-017560 7957
2022-09-14 4 FORM 4 0001567619-22-017433 8736
2022-09-12 SC 13G/A MS AMENDMENT 0000895421-22-000558 005-91164 221238858 34 17555
2022-08-25 4 FORM 4 0001567619-22-016679 3312
2022-08-25 4 FORM 4 0001567619-22-016678 6521
2022-08-25 4 FORM 4 0001567619-22-016677 4785
2022-08-25 4 FORM 4 0001567619-22-016676 4844
2022-08-09 SC 13G/A us88025u1097_080822.txt 0000834237-22-010506 005-91164 221148113 34 13486
2022-08-09 10-Q 10-Q 0001770787-22-000049 001-39035 221145988 34 5721380 1 1
2022-08-08 8-K 8-K 2.02,9.01 0001770787-22-000047 001-39035 221144312 34 1031235 1 1
2022-08-03 3 FORM 3 0001567619-22-014903 12522
2022-08-03 8-K 8-K 2.05 0001770787-22-000040 001-39035 221133591 34 693945 1 1
2022-07-14 8-K 8-K 2.02,8.01,9.01 0001770787-22-000036 001-39035 221083085 34 1144621 1 1
2022-06-17 4 FORM 4 0001567619-22-013129 10473
2022-06-17 4 FORM 4 0001567619-22-013122 7426
2022-06-17 4 FORM 4 0001567619-22-013121 7406
2022-06-17 4 FORM 4 0001567619-22-013120 7364
2022-06-17 4 FORM 4 0001567619-22-013119 7386
2022-06-17 4 FORM 4 0001567619-22-013118 8250
2022-06-17 8-K 8-K 5.07 0001770787-22-000032 001-39035 221023776 34 714312 1 1
2022-06-09 4 FORM 4 0001567619-22-012617 6320
2022-05-25 4 FORM 4 0001567619-22-011714 6520
2022-05-25 4 FORM 4 0001567619-22-011713 4784
2022-05-25 4 FORM 4 0001567619-22-011712 4843
2022-05-25 4 FORM 4 0001567619-22-011711 4762
2022-05-17 4 FORM 4 0001567619-22-011125 7960
2022-05-17 4 FORM 4 0001567619-22-011123 4803
2022-05-17 4 FORM 4 0001567619-22-011119 4781
2022-05-09 SC 13G us88025u1097_050922.txt 0000834237-22-009647 005-91164 22904563 34 13678
2022-05-05 10-Q 10-Q 0001770787-22-000029 001-39035 22896173 34 4982619 1 1
2022-05-04 8-K 8-K 2.02,9.01 0001770787-22-000026 001-39035 22891503 34 1011565 1 1
2022-04-29 DEFA14A DEFA14A 0001770787-22-000023 001-39035 22875620 34 690935
2022-04-29 DEF 14A DEF 14A 0001770787-22-000022 001-39035 22875312 34 1739252
2022-03-24 4 FORM 4 0001567619-22-007442 7425
2022-03-24 4 FORM 4 0001567619-22-007440 7367
2022-03-24 4 FORM 4 0001567619-22-007438 9106
2022-02-24 4 FORM 4 0001567619-22-005522 12605
2022-02-24 4 FORM 4 0001567619-22-005521 6501
2022-02-24 4 FORM 4 0001567619-22-005520 4762
2022-02-24 4 FORM 4 0001567619-22-005519 4737
2022-02-18 S-8 S-8 0001770787-22-000017 333-262863 22652993 33 561461
2022-02-18 10-K 10-K 0001770787-22-000015 001-39035 22652718 34 33429882 1 1
2022-02-17 4 FORM 4 0001567619-22-004884 9145
2022-02-16 8-K 8-K 2.02,9.01 0001770787-22-000004 001-39035 22643560 34 1039466 1 1
2022-02-14 SC 13G/A SC 13G/A 0001104659-22-022742 005-91164 22631884 34 84389
2022-02-10 4 FORM 4 0001567619-22-003272 16722
2022-02-09 SC 13G/A SCHEDULE 13G/A 0001104659-22-016336 005-91164 22606192 34 13040
2022-02-09 SC 13G/A MS AMENDMENT 0000895421-22-000023 005-91164 22604987 34 17733
2022-02-09 SC 13G/A filing.txt 0000315066-22-000740 005-91164 22604057 34 10768
2022-02-03 SC 13G/A us88025u1097_020322.txt 0000834237-22-006444 005-91164 22589206 34 13632
2022-01-18 SC 13G 10xGenomics31122021.txt 0001088875-22-000013 005-91164 22533586 34 11173
2022-01-14 4 FORM 4 0001567619-22-001197 22799
2022-01-06 4 FORM 4 0001567619-22-000817 22585
2022-01-05 4 FORM 4 0001567619-22-000622 16948
2022-01-05 4 FORM 4 0001567619-22-000621 22877
2022-01-04 4 FORM 4 0001567619-22-000372 6119
2022-01-04 4 FORM 4 0001567619-22-000366 7161
2021-12-30 4 FORM 4 0001567619-21-022725 9572
2021-12-30 4 FORM 4 0001567619-21-022724 10331
2021-12-23 4 FORM 4 0001567619-21-022503 10802
2021-12-15 4 FORM 4 0001567619-21-022118 18404
2021-12-10 SC 13G/A filing.txt 0000315066-21-001903 005-91164 211483789 34 10760
2021-12-09 4 FORM 4 0001567619-21-021857 27967
2021-12-03 4 FORM 4 0001567619-21-021618 26207
2021-12-03 4 FORM 4 0001567619-21-021615 33624
2021-12-03 4 FORM 4 0001567619-21-021614 12043
2021-11-29 4 FORM 4 0001567619-21-021235 6120
2021-11-24 4 FORM 4 0001567619-21-021189 4764
2021-11-24 4 FORM 4 0001567619-21-021188 4739
2021-11-24 4 FORM 4 0001567619-21-021187 4819
2021-11-24 4 FORM 4 0001567619-21-021186 6503
2021-11-18 4 FORM 4 0001567619-21-020783 10577
2021-11-16 4 FORM 4 0001567619-21-020599 17925
2021-11-05 10-Q 10-Q 0001770787-21-000054 001-39035 211384536 34 7101905 1 1
2021-11-04 4 FORM 4 0001567619-21-019360 20164
2021-11-03 4 FORM 4 0001567619-21-019299 16949
2021-11-03 4 FORM 4 0001567619-21-019298 13508
2021-11-03 4 FORM 4 0001567619-21-019297 20927
2021-11-03 8-K 8-K 2.02,9.01 0001770787-21-000048 001-39035 211375318 34 835298 1 1
2021-10-27 4 FORM 4 0001567619-21-018801 13592
2021-10-20 4 FORM 4 0001567619-21-018503 9109
2021-10-14 4 FORM 4 0001567619-21-018312 13045
2021-10-12 4 FORM 4 0001567619-21-018209 5212
2021-10-07 4 FORM 4 0001567619-21-018030 22597
2021-10-05 4 FORM 4 0001567619-21-017949 15004

Latest XBRL company facts

One latest value per concept from companyfacts (334 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityPublicFloat Entity Public Float USD 1.30B 2025-06-30 2025 FY 10-K 2026-02-13 0001628280-26-007822
ecd CoSelectedMeasureAmt CoSelectedMeasureAmt USD 16.31 2025-01-01 2025-12-31 DEF 14A 2026-04-24 0001628280-26-027201
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 3.67M 2025-01-01 2025-12-31 DEF 14A 2026-04-24 0001628280-26-027201
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 2.76M 2025-01-01 2025-12-31 DEF 14A 2026-04-24 0001628280-26-027201
ecd PeerGroupTotalShareholderRtnAmt PeerGroupTotalShareholderRtnAmt USD 124.75 2025-01-01 2025-12-31 DEF 14A 2026-04-24 0001628280-26-027201
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD 6.79M 2025-01-01 2025-12-31 DEF 14A 2026-04-24 0001628280-26-027201
ecd PeoTotalCompAmt PeoTotalCompAmt USD 6.33M 2025-01-01 2025-12-31 DEF 14A 2026-04-24 0001628280-26-027201
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 11.52 2025-01-01 2025-12-31 DEF 14A 2026-04-24 0001628280-26-027201
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 21.59M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 55.70M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD -871,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-16 0001770787-23-000012
us-gaap AccruedBonusesCurrent Accrued Bonuses, Current USD 23.25M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 4.56M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap AccruedRoyaltiesCurrent Accrued Royalties, Current USD 4.06M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap AccruedVacationCurrent Accrued Vacation, Current USD 1.09M 2022-09-30 2022 Q3 10-Q 2022-11-03 0001770787-22-000057
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 174.76M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD 197,000 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 2.40B 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 23.27M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 150,000 2018-01-01 2018-12-31 2019 FY 10-K 2020-02-27 0001193125-20-052640
us-gaap AdvertisingExpense Advertising Expense USD 2.50M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 71.35M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap AllowanceForDoubtfulAccountsReceivableCurrent Accounts Receivable, Allowance for Credit Loss, Current USD 100,000 2025-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap AmortizationOfDebtDiscountPremium Amortization of Debt Discount (Premium) USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-16 0001770787-23-000012
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 10.53M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap AssetAcquisitionContingentConsiderationLiabilityCurrent AssetAcquisitionContingentConsiderationLiabilityCurrent USD 12.04M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap AssetAcquisitionContingentConsiderationLiabilityNoncurrent AssetAcquisitionContingentConsiderationLiabilityNoncurrent USD 5.84M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 3.05M 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-13 0001770787-25-000013
us-gaap Assets Assets USD 1.06B 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap AssetsCurrent Assets, Current USD 718.63M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 0 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 45,000 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 223.62M 2022-09-30 2022 Q3 10-Q 2022-11-03 0001770787-22-000057
us-gaap AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five USD 93.42M 2022-09-30 2022 Q3 10-Q 2022-11-03 0001770787-22-000057
us-gaap AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five USD 269,000 2024-06-30 2024 Q2 10-Q 2024-08-08 0001770787-24-000060
us-gaap AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One USD 130.21M 2022-09-30 2022 Q3 10-Q 2022-11-03 0001770787-22-000057
us-gaap AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One USD 0 2024-06-30 2024 Q2 10-Q 2024-08-08 0001770787-24-000060
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 269,000 2024-06-30 2024 Q2 10-Q 2024-08-08 0001770787-24-000060
us-gaap AvailableForSaleSecuritiesDebtSecuritiesCurrent Debt Securities, Available-for-sale, Current USD 49.49M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap BusinessCombinationConsiderationTransferred1 Business Combination, Consideration Transferred USD 8.50M 2021-01-08 2021 Q1 10-Q 2021-05-07 0001770787-21-000031
us-gaap BusinessCombinationContingentConsiderationLiability Business Combination, Contingent Consideration, Liability USD 1.50M 2021-01-08 2021 Q1 10-Q 2021-05-07 0001770787-21-000031
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net USD 38.56M 2019-12-31 2019 FY 10-K 2020-02-27 0001193125-20-052640
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 54,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 344.07M 2024-12-31 2024 FY 10-K 2025-02-13 0001770787-25-000013
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 526.19M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 52.22M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 526.19M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2025-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 1.10B 2025-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 127.69M 2025-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 127.69M 2025-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap CommonStockValue Common Stock, Value, Issued USD 2,000 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -50.85M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap ContractualObligation Contractual Obligation USD 10.20M 2020-12-31 2020 FY 10-K 2021-02-26 0001770787-21-000009
us-gaap ContractWithCustomerLiability Contract with Customer, Liability USD 31.49M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 22.96M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap ContractWithCustomerLiabilityNoncurrent Contract with Customer, Liability, Noncurrent USD 8.53M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap ContractWithCustomerLiabilityRevenueRecognized Contract with Customer, Liability, Revenue Recognized USD -19.31M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap ConversionOfStockAmountConverted1 Conversion of Stock, Amount Converted USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-18 0001770787-22-000015
us-gaap CostOfRevenue Cost of Revenue USD 120.94M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD -7,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap CurrentForeignTaxExpenseBenefit Current Foreign Tax Expense (Benefit) USD 3.56M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 3.95M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 397,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap DebtInstrumentCarryingAmount Long-term Debt, Gross USD 30.00M 2019-12-31 2019 FY 10-K 2020-02-27 0001193125-20-052640
us-gaap DebtInstrumentUnamortizedDiscount Debt Instrument, Unamortized Discount USD 281,000 2019-12-31 2019 FY 10-K 2020-02-27 0001193125-20-052640
us-gaap DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction USD 0 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-05 0001770787-21-000054
us-gaap DebtSecuritiesAvailableForSaleRealizedGain Debt Securities, Available-for-sale, Realized Gain USD 0 2023-01-01 2023-09-30 2024 Q3 10-Q 2024-10-29 0001770787-24-000073
us-gaap DebtSecuritiesAvailableForSaleRealizedGainLoss Debt Securities, Available-for-sale, Realized Gain (Loss) USD 0 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-07 0001628280-25-050332
us-gaap DebtSecuritiesAvailableForSaleRealizedLoss Debt Securities, Available-for-sale, Realized Loss USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap DeferredCompensationLiabilityClassifiedNoncurrent Deferred Compensation Liability, Classified, Noncurrent USD 494,000 2019-12-31 2020 FY 10-K 2021-02-26 0001770787-21-000009
us-gaap DeferredCompensationLiabilityCurrent Deferred Compensation Liability, Current USD 247,000 2020-12-31 2020 FY 10-K 2021-02-26 0001770787-21-000009
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap DeferredForeignIncomeTaxExpenseBenefit Deferred Foreign Income Tax Expense (Benefit) USD -310,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD -1.43M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 16.29M 2025-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap DeferredRentCreditNoncurrent Deferred Rent Credit, Noncurrent USD 16.12M 2019-12-31 2020 FY 10-K 2021-02-26 0001770787-21-000009
us-gaap DeferredStateAndLocalIncomeTaxExpenseBenefit Deferred State and Local Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap DeferredTaxAssetsGoodwillAndIntangibleAssets Deferred Tax Assets, Goodwill and Intangible Assets USD 27.84M 2025-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 505.84M 2025-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 111.14M 2025-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 7,000 2019-12-31 2020 FY 10-K 2021-02-26 0001770787-21-000009
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 15.69M 2025-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 202.70M 2025-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 24.38M 2025-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap DeferredTaxAssetsTaxDeferredExpenseOther Deferred Tax Assets, Tax Deferred Expense, Other USD 2.77M 2019-12-31 2019 FY 10-K 2020-02-27 0001193125-20-052640
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Reserves USD 17.32M 2025-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 490.15M 2025-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap DeferredTaxLiabilities Deferred Tax Liabilities, Net USD 605,000 2025-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 2.85M 2025-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap DefinedBenefitPlanContributionsByEmployer Defined Benefit Plan, Plan Assets, Contributions by Employer USD 1.90M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap DefinedContributionPlanEmployerMatchingContributionPercentOfMatch Defined Contribution Plan, Employer Matching Contribution, Percent of Match pure 0.03 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage Defined Contribution Plan, Employers Matching Contribution, Annual Vesting Percentage pure 1 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap Depreciation Depreciation USD 31.20M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 29.13M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.39 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -5.37 2020-01-01 2020-12-31 2020 FY 10-K 2021-02-26 0001770787-21-000009
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.39 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure -0.09 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure 0.13 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectAmount EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectAmount USD 336,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectPercent EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectPercent pure -0.01 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure -0.01 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.37 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount USD 36.38M 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0.06 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap EffectiveIncomeTaxRateReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Percent pure -0.15 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure -0.11 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD -282,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 39.66M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap FederalIncomeTaxExpenseBenefitContinuingOperations Federal Income Tax Expense (Benefit), Continuing Operations USD -37.32M 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap FinanceLeaseRightOfUseAssetAmortization Finance Lease, Right-of-Use Asset, Amortization USD 7.62M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap FiniteLivedIntangibleAssetsAccumulatedAmortization Finite-Lived Intangible Assets, Accumulated Amortization USD 22.45M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive Finite-Lived Intangible Asset, Expected Amortization, after Year Five USD 14.29M 2025-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths Finite-Lived Intangible Asset, Expected Amortization, Year One USD 9.64M 2025-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year USD 645,000 2021-09-30 2021 Q3 10-Q 2021-11-05 0001770787-21-000054
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFive Finite-Lived Intangible Asset, Expected Amortization, Year Five USD 9.57M 2025-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFour Finite-Lived Intangible Asset, Expected Amortization, Year Four USD 9.61M 2025-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearThree Finite-Lived Intangible Asset, Expected Amortization, Year Three USD 9.61M 2025-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo Finite-Lived Intangible Asset, Expected Amortization, Year Two USD 9.61M 2025-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap FiniteLivedIntangibleAssetsFairValueDisclosure Finite-lived Intangible Assets, Fair Value Disclosure USD 22.10M 2019-10-31 2019 FY 10-K 2020-02-27 0001193125-20-052640
us-gaap FiniteLivedIntangibleAssetsGross Finite-Lived Intangible Assets, Gross USD 81.11M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 58.66M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap ForeignCurrencyTransactionGainLossBeforeTax Foreign Currency Transaction Gain (Loss), before Tax USD 2.50M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap ForeignCurrencyTransactionGainLossRealizedAfterTax ForeignCurrencyTransactionGainLossRealizedAfterTax USD -700,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap ForeignIncomeTaxExpenseBenefitContinuingOperations Foreign Income Tax Expense (Benefit), Continuing Operations USD 2.15M 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD -1.09M 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-16 0001770787-23-000012
us-gaap GainLossOnTerminationOfLease Gain (Loss) on Termination of Lease USD -1.00M 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-13 0001770787-25-000013
us-gaap GainLossRelatedToLitigationSettlement Gain (Loss) Related to Litigation Settlement USD 25.00M 2023-11-17 2025 Q1 10-Q 2025-05-09 0001770787-25-000032
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-16 0001770787-23-000012
us-gaap Goodwill Goodwill USD 6.92M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap GrossProfit Gross Profit USD 331.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 100,000 2025-01-01 2025-06-30 2026 Q2 10-Q 2026-08-07 0001628280-26-054491
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -49.97M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 1.77M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap IncomeTaxExaminationPenaltiesAndInterestAccrued Income Tax Examination, Penalties and Interest Accrued USD 2.10M 2025-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap IncomeTaxExaminationPenaltiesAndInterestExpense Income Tax Examination, Penalties and Interest Expense USD 600,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 858,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap IncomeTaxPaidStateAndLocalAfterRefundReceived IncomeTaxPaidStateAndLocalAfterRefundReceived USD 195,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD -5.04M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -8.38M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 503,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 14.55M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD 383,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD -2.36M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap IncomeTaxReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Amount USD 5.87M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap IncomeTaxReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Amount USD 8.89M 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 4.25M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 8.95M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 8.69M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD -613,000 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-08 0001628280-26-032388
us-gaap IncreaseDecreaseInContractWithCustomerLiability Increase (Decrease) in Contract with Customer, Liability USD 3.35M 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-16 0001770787-23-000012
us-gaap IncreaseDecreaseInDeferredLiabilities Increase (Decrease) in Deferred Liabilities USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-18 0001770787-22-000015
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD -3.32M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap IncreaseDecreaseInEmployeeRelatedLiabilities Increase (Decrease) in Employee Related Liabilities USD -2.90M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD 6.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -9.02M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap IncreaseDecreaseInOtherNoncurrentLiabilities Increase (Decrease) in Other Noncurrent Liabilities USD 31,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD 9.85M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap IncreaseDecreaseInOtherReceivables Increase (Decrease) in Other Receivables USD -32.18M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD -1.97M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap IncrementalCommonSharesAttributableToShareBasedPaymentArrangements Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements shares 0 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-07 0001628280-26-054491
us-gaap IntangibleAssetsNetExcludingGoodwill Intangible Assets, Net (Excluding Goodwill) USD 58.66M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap InterestExpense Interest Expense USD 1,000 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-04-30 0001770787-24-000036
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap InventoryFinishedGoodsNetOfReserves Inventory, Finished Goods, Net of Reserves USD 14.12M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap InventoryNet Inventory, Net USD 64.63M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap InventoryRawMaterialsAndSuppliesNetOfReserves Inventory, Raw Materials and Supplies, Net of Reserves USD 26.11M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap InventoryWorkInProcessNetOfReserves Inventory, Work in Process, Net of Reserves USD 24.39M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 14.83M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap LeaseAndRentalExpense Operating Leases, Rent Expense USD 6.80M 2019-01-01 2019-12-31 2019 FY 10-K 2020-02-27 0001193125-20-052640
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 90.95M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 29.54M 2025-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 17.04M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 9.85M 2025-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 9.85M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 14.80M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 16.39M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 3.29M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 15.16M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap Liabilities Liabilities USD 225.09M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 1.06B 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap LiabilitiesCurrent Liabilities, Current USD 140.37M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap LitigationReserveCurrent Estimated Litigation Liability, Current USD 23.36M 2025-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap LitigationReserveNoncurrent Estimated Litigation Liability, Noncurrent USD 1.24M 2025-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap LitigationSettlementGain LitigationSettlementGain USD 3.40M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap LongTermDebt Long-term Debt USD 29.72M 2019-12-31 2019 FY 10-K 2020-02-27 0001193125-20-052640
us-gaap LongTermDebtCurrent Long-term Debt, Current Maturities USD 0 2020-12-31 2020 FY 10-K 2021-02-26 0001770787-21-000009
us-gaap LongTermDebtNoncurrent Long-term Debt, Excluding Current Maturities USD 0 2020-12-31 2020 FY 10-K 2021-02-26 0001770787-21-000009
us-gaap LossContingencyAccrualProvision Loss Contingency Accrual, Provision USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-15 0001770787-24-000017
us-gaap LossContingencyDamagesSoughtValue Loss Contingency, Damages Sought, Value USD 31.00M 2023-11-17 2025 Q1 10-Q 2025-05-09 0001770787-25-000032
us-gaap MarketableSecuritiesRealizedGainLoss Marketable Securities, Realized Gain (Loss) USD -1.72M 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-04 0001770787-23-000029
us-gaap MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment Loss USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 3.13M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -9.55M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD 58.93M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -50.83M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap NoncashOrPartNoncashAcquisitionOtherLiabilitiesAssumed1 Noncash or Part Noncash Acquisition, Other Liabilities Assumed USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-16 0001770787-23-000012
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 2.69M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap NumberOfOperatingSegments Number of Operating Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap NumberOfReportableSegments Number of Reportable Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap OperatingExpenses Operating Expenses USD 384.26M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -52.66M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap OperatingLeaseCost Operating Lease, Cost USD 12.50M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap OperatingLeaseImpairmentLoss Operating Lease, Impairment Loss USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 75.79M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 11.95M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 63.85M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap OperatingLeasePayments Operating Lease, Payments USD 16.20M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 54.76M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 6.07M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 72.98M 2019-12-31 2020 FY 10-K 2021-02-26 0001770787-21-000009
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 6.25M 2019-12-31 2020 FY 10-K 2021-02-26 0001770787-21-000009
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 7.06M 2019-12-31 2020 FY 10-K 2021-02-26 0001770787-21-000009
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 6.95M 2019-12-31 2020 FY 10-K 2021-02-26 0001770787-21-000009
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 6.79M 2019-12-31 2020 FY 10-K 2021-02-26 0001770787-21-000009
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 7.58M 2019-12-31 2020 FY 10-K 2021-02-26 0001770787-21-000009
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 38.35M 2019-12-31 2020 FY 10-K 2021-02-26 0001770787-21-000009
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.059 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 13.92M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent USD 29,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax USD -241,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-16 0001770787-23-000012
us-gaap OtherComprehensiveIncomeLossNetOfTax Other Comprehensive Income (Loss), Net of Tax USD -3.99M 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-09 0001770787-22-000049
us-gaap OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent USD -28,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, before Tax USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap OtherComprehensiveIncomeLossTaxPortionAttributableToParent1 Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent USD 5.51M 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-03 0001770787-22-000057
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD -57,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap OtherEmployeeRelatedLiabilitiesCurrent Other Employee-related Liabilities, Current USD 4.95M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 8.26M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 6.50M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap OtherNoncashExpense Other Noncash Expense USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-16 0001770787-23-000012
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD -12.14M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap OtherOperatingActivitiesCashFlowStatement Other Operating Activities, Cash Flow Statement USD -962,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap OtherReceivablesNetCurrent Other Receivables, Net, Current USD 3.06M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap PaymentForContingentConsiderationLiabilityFinancingActivities Payment for Contingent Consideration Liability, Financing Activities USD 8.69M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap PaymentsForRepurchaseOfCommonStock Payments for Repurchase of Common Stock USD 80,000 2017-01-01 2017-12-31 2019 FY 10-K 2020-02-27 0001193125-20-052640
us-gaap PaymentsForRestructuring Payments for Restructuring USD 7.74M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap PaymentsForRoyalties Payments for Royalties USD 6.00M 2023-11-17 2025 Q1 10-Q 2025-05-09 0001770787-25-000032
us-gaap PaymentsOfFinancingCosts Payments of Financing Costs USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 0 2020-01-01 2020-06-30 2020 Q2 10-Q 2020-08-12 0001628280-20-012520
us-gaap PaymentsToAcquireAvailableForSaleSecuritiesDebt Payments to Acquire Debt Securities, Available-for-sale USD 73.79M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap PaymentsToAcquireBusinessesNetOfCashAcquired Payments to Acquire Businesses, Net of Cash Acquired USD 6.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap PaymentsToAcquireIntangibleAssets Payments to Acquire Intangible Assets USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 4.16M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2025-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 100.00M 2025-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2025-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2025-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 19.57M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-16 0001770787-23-000012
us-gaap ProceedsFromIssuanceOfLongTermDebt Proceeds from Issuance of Long-term Debt USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-02-26 0001770787-21-000009
us-gaap ProceedsFromIssuanceOfPreferredStockAndPreferenceStock Proceeds from Issuance of Preferred Stock and Preference Stock USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-02-26 0001770787-21-000009
us-gaap ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised USD 11.81M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap ProceedsFromLinesOfCredit Proceeds from Lines of Credit USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-18 0001770787-22-000015
us-gaap ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale USD 75.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities Proceeds from Sale and Maturity of Debt Securities, Available-for-sale USD 12.91M 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-05 0001770787-22-000029
us-gaap ProceedsFromSaleOfHeldToMaturitySecurities Proceeds from Sale of Held-to-maturity Securities USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 21.23M 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-16 0001770787-23-000012
us-gaap ProductWarrantyAccrual Standard and Extended Product Warranty Accrual USD 3.31M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap ProductWarrantyAccrualClassifiedCurrent Product Warranty Accrual, Current USD 3.31M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap ProductWarrantyAccrualPayments Standard and Extended Product Warranty Accrual, Decrease for Payments USD 5.24M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap ProductWarrantyAccrualWarrantiesIssued Standard and Extended Product Warranty Accrual, Increase for Warranties Issued USD 1.72M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 385.00M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 210.24M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap PurchaseObligation Purchase Obligation USD 12.20M 2025-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap RepaymentsOfLinesOfCredit Repayments of Lines of Credit USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-18 0001770787-22-000015
us-gaap RepaymentsOfLongTermDebt Repayments of Long-term Debt USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-16 0001770787-23-000012
us-gaap ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost Research and Development Expense (Excluding Acquired in Process Cost) USD 166.57M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap ResearchAndDevelopmentInProcess Research and Development in Process USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-02-16 0001770787-23-000012
us-gaap RestrictedCash Restricted Cash USD 0 2024-12-31 2024 FY 10-K 2025-02-13 0001770787-25-000013
us-gaap RestrictedCashCurrent Restricted Cash, Current USD 0 2023-12-31 2023 FY 10-K 2024-02-15 0001770787-24-000017
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 201,000 2025-09-30 2025 Q3 10-Q 2025-11-07 0001628280-25-050332
us-gaap RestructuringCharges Restructuring Charges USD 10.59M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap RestructuringCosts Restructuring Costs USD 2.50M 2023-01-01 2023-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap RestructuringCostsAndAssetImpairmentCharges Restructuring Costs and Asset Impairment Charges USD 1.25M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap RestructuringReserve Restructuring Reserve USD 1.29M 2025-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap RestructuringReserveSettledWithoutCash2 Restructuring Reserve, Settled without Cash USD 314,000 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-07 0001628280-25-050332
us-gaap RestructuringReserveTranslationAndOtherAdjustment Restructuring Reserve, Translation and Other Adjustment USD -1.57M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -1.56B 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 452.55M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap RevenueRemainingPerformanceObligation Revenue, Remaining Performance Obligation, Amount USD 34.40M 2025-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap RevenueRemainingPerformanceObligationPercentage Revenue, Remaining Performance Obligation, Percentage pure 0.74 2020-03-31 2020 Q1 10-Q 2020-05-12 0001193125-20-140382
us-gaap Revenues Revenues USD 71.91M 2020-01-01 2020-03-31 2020 Q1 10-Q 2020-05-12 0001193125-20-140382
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap SecurityDeposit Security Deposit USD 2.30M 2023-12-20 2025 Q1 10-Q 2025-05-09 0001770787-25-000032
us-gaap SellingGeneralAndAdministrativeExpense Selling, General and Administrative Expense USD 221.09M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 71.35M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period shares 717,295 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-07 0001628280-26-054491
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value USD/shares 19.31 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-07 0001628280-26-054491
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period shares 3.51M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-07 0001628280-26-054491
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 23.49 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-07 0001628280-26-054491
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number shares 8.76M 2026-06-30 2026 Q2 10-Q 2026-08-07 0001628280-26-054491
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value USD/shares 20.52 2026-06-30 2026 Q2 10-Q 2026-08-07 0001628280-26-054491
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period shares 1.86M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-07 0001628280-26-054491
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value USD/shares 23.08 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-07 0001628280-26-054491
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2023-01-01 2023-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 53,462 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-07 0001628280-26-054491
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 357,457 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-03 0001770787-23-000053
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 3.39M 2026-06-30 2026 Q2 10-Q 2026-08-07 0001628280-26-054491
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 50.13 2026-06-30 2026 Q2 10-Q 2026-08-07 0001628280-26-054491
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 3.86 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-07 0001628280-26-054491
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 45.79 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-07 0001628280-26-054491
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 52.18 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-03 0001770787-23-000053
us-gaap StateAndLocalIncomeTaxExpenseBenefitContinuingOperations State and Local Income Tax Expense (Benefit), Continuing Operations USD -11.94M 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 838.04M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap StockIssued1 Stock Issued USD 8.70M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 117,009 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-07 0001628280-26-054491
us-gaap StockIssuedDuringPeriodValueAcquisitions Stock Issued During Period, Value, Acquisitions USD 13.54M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 410.82M 2019-07-01 2019-09-30 2020 Q3 10-Q 2020-11-12 0001770787-20-000009
us-gaap SubleaseIncome Sublease Income USD 600,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap TaxesPayableCurrent Taxes Payable, Current USD 6.97M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 243.24M 2018-12-31 2019 FY 10-K 2020-02-27 0001193125-20-052640
us-gaap TemporaryEquityLiquidationPreference Temporary Equity, Liquidation Preference USD 242.59M 2018-12-31 2019 FY 10-K 2020-02-27 0001193125-20-052640
us-gaap TemporaryEquityParOrStatedValuePerShare Temporary Equity, Par or Stated Value Per Share USD/shares 0 2019-12-31 2019 FY 10-K 2020-02-27 0001193125-20-052640
us-gaap TemporaryEquitySharesAuthorized Temporary Equity, Shares Authorized shares 0 2019-12-31 2019 FY 10-K 2020-02-27 0001193125-20-052640
us-gaap TemporaryEquitySharesIssued Temporary Equity, Shares Issued shares 0 2019-12-31 2019 FY 10-K 2020-02-27 0001193125-20-052640
us-gaap TemporaryEquitySharesOutstanding Temporary Equity, Shares Outstanding shares 67.70M 2019-03-31 2020 Q1 10-Q 2020-05-12 0001193125-20-140382
us-gaap UnrealizedGainLossOnInvestments Unrealized Gain (Loss) on Investments USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-02-27 0001193125-20-052640
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 55.49M 2025-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions USD 739,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition Unrecognized Tax Benefits, Increase Resulting from Acquisition USD 2.29M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 3.48M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions USD 436,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate Unrecognized Tax Benefits that Would Impact Effective Tax Rate USD 3.30M 2025-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 10.70M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap VariableLeaseCost Variable Lease, Cost USD 1.00M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-13 0001628280-26-007822
us-gaap WarrantsNotSettleableInCashFairValueDisclosure Warrants Not Settleable in Cash, Fair Value Disclosure USD 150,000 2018-02-28 2019 FY 10-K 2020-02-27 0001193125-20-052640
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 129.57M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 101.15M 2020-01-01 2020-12-31 2020 FY 10-K 2021-02-26 0001770787-21-000009
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 129.57M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001628280-26-071199

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →